Benjamin Esterni

6.9k total citations · 1 hit paper
75 papers, 4.4k citations indexed

About

Benjamin Esterni is a scholar working on Oncology, Hematology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Benjamin Esterni has authored 75 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Oncology, 19 papers in Hematology and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Benjamin Esterni's work include Acute Myeloid Leukemia Research (14 papers), Hematopoietic Stem Cell Transplantation (11 papers) and Breast Cancer Treatment Studies (11 papers). Benjamin Esterni is often cited by papers focused on Acute Myeloid Leukemia Research (14 papers), Hematopoietic Stem Cell Transplantation (11 papers) and Breast Cancer Treatment Studies (11 papers). Benjamin Esterni collaborates with scholars based in France, United States and Italy. Benjamin Esterni's co-authors include Daniel Birnbaum, Patrice Viens, François Bertucci, Pascal Finetti, Jocelyne Jacquemier, Nathalie Cervera, Emmanuelle Charafe‐Jauffret, Luc Xerri, Norbert Vey and Christian Chabannon and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Benjamin Esterni

74 papers receiving 4.3k citations

Hit Papers

Aldehyde Dehydrogenase 1–Positive Cancer Stem Cells Media... 2009 2026 2014 2020 2009 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Aldehyde Dehydrogenase 1–Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer
    2009 575 citations Emmanuelle Charafe‐Jauffret, Christophe Ginestier et al. Clinical Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benjamin Esterni France 32 2.2k 1.4k 1.0k 1.0k 683 75 4.4k
Nashat Gabrail United States 26 2.3k 1.1× 1.6k 1.1× 828 0.8× 1.1k 1.0× 788 1.2× 154 4.4k
Marco Danova Italy 30 1.6k 0.7× 1.1k 0.8× 553 0.5× 634 0.6× 576 0.8× 226 3.5k
Lia Gore United States 43 2.6k 1.2× 2.6k 1.8× 1.1k 1.1× 632 0.6× 821 1.2× 202 6.1k
Giannoula Klement United States 29 1.7k 0.8× 2.3k 1.6× 847 0.8× 1.2k 1.2× 666 1.0× 67 4.9k
Mohamed Hebbar France 37 2.0k 0.9× 1.2k 0.9× 427 0.4× 473 0.5× 761 1.1× 151 4.6k
David Boulware United States 41 1.5k 0.7× 1.6k 1.1× 641 0.6× 845 0.8× 924 1.4× 122 5.4k
Peter Langmuir United States 30 1.8k 0.8× 1.3k 0.9× 555 0.5× 507 0.5× 1.6k 2.4× 56 4.7k
J Garcı́a-Conde Spain 35 2.0k 0.9× 954 0.7× 984 0.9× 584 0.6× 425 0.6× 104 3.9k
Margaret Dugan United States 29 2.5k 1.1× 1.9k 1.3× 1.4k 1.3× 1.4k 1.4× 1.3k 1.9× 71 6.2k
Barbara Schmalfeldt Germany 33 1.5k 0.7× 1.2k 0.8× 327 0.3× 855 0.8× 386 0.6× 130 4.2k

Countries citing papers authored by Benjamin Esterni

Since Specialization
Citations

This map shows the geographic impact of Benjamin Esterni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Esterni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Esterni more than expected).

Fields of papers citing papers by Benjamin Esterni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Esterni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Esterni. The network helps show where Benjamin Esterni may publish in the future.

Co-authorship network of co-authors of Benjamin Esterni

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin Esterni. A scholar is included among the top collaborators of Benjamin Esterni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin Esterni. Benjamin Esterni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Houvenaeghel, Gilles, Jean‐Marc Classe, Jean-Rémy Garbay, et al.. (2014). Prognostic value of isolated tumor cells and micrometastases of lymph nodes in early-stage breast cancer: A French sentinel node multicenter cohort study. The Breast. 23(5). 561–566. 30 indexed citations
2.
Gilabert, Marine, François Bertucci, Benjamin Esterni, et al.. (2011). Capecitabine after anthracycline and taxane exposure in HER2-negative metastatic breast cancer patients: response, survival and prognostic factors.. PubMed. 31(3). 1079–86. 15 indexed citations
3.
Jacquemier, Jocelyne, François Bertucci, Pascal Finetti, et al.. (2011). High expression of indoleamine 2,3‐dioxygenase in the tumour is associated with medullary features and favourable outcome in basal‐like breast carcinoma. International Journal of Cancer. 130(1). 96–104. 73 indexed citations
4.
Sabatier, Renaud, Pascal Finetti, Nathalie Cervera, et al.. (2010). A gene expression signature identifies two prognostic subgroups of basal breast cancer. Breast Cancer Research and Treatment. 126(2). 407–420. 210 indexed citations
5.
Cheikh, Jean El, Luca Castagna, Ling Wang, et al.. (2010). Once-weekly liposomal amphotericin B for prophylaxis of invasive fungal infection after graft-versus-host disease in allogeneic hematopoietic stem cell transplantation. Hematology/Oncology and Stem Cell Therapy. 3(4). 167–173. 17 indexed citations
6.
Prébet, Thomas, Anne Etienne, Raynier Devillier, et al.. (2010). Improved outcome of patients with low‐ and intermediate‐risk cytogenetics acute myeloid leukemia (AML) in first relapse with gemtuzumab and cytarabine versus cytarabine. Cancer. 117(5). 974–981. 14 indexed citations
7.
Rousseau, Frédérique, R. Bugat, Michel Ducreux, et al.. (2010). Effect of XELOX on functional ability among elderly patients with metastatic colorectal cancer: Results from the FNCLCC/GERICO 02 phase II study. Journal of Geriatric Oncology. 2(2). 105–111.
8.
Cheikh, Jean El, Luca Castagna, Ling Wang, et al.. (2010). Impact of prior invasive aspergillosis on outcome in patients receiving reduced-intensity conditioning allogeneic hematopoietic stem cell transplant. Leukemia & lymphoma. 51(9). 1–6. 12 indexed citations
9.
Jacquemier, Jocelyne, Emmanuelle Charafe‐Jauffret, Florence Monville, et al.. (2009). Association of GATA3, P53, Ki67 status and vascular peritumoral invasion are strongly prognostic in luminal breast cancer. Breast Cancer Research. 11(2). R23–R23. 69 indexed citations
10.
Charafe‐Jauffret, Emmanuelle, Christophe Ginestier, Flora Iovino, et al.. (2009). Aldehyde Dehydrogenase 1–Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer. Clinical Cancer Research. 16(1). 45–55. 575 indexed citations breakdown →
11.
Jacquemier, Jocelyne, Pascal Finetti, Thomas Moreau, et al.. (2009). CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines. Breast Cancer Research. 11(1). R1–R1. 122 indexed citations
12.
13.
Mrad, Karima, Emmanuelle Charafe‐Jauffret, Saïda Ben Arab, et al.. (2008). Markers of subtypes in inflammatory breast cancer studied by immunohistochemistry: Prominent expression of P-cadherin. BMC Cancer. 8(1). 28–28. 28 indexed citations
14.
Bertucci, François, Pascal Finetti, Nathalie Cervera, et al.. (2008). How basal are triple‐negative breast cancers?. International Journal of Cancer. 123(1). 236–240. 365 indexed citations
15.
Charafe‐Jauffret, Emmanuelle, Karima Mrad, Sana Intidhar Labidi‐Galy, et al.. (2007). Inflammatory breast cancers in Tunisia and France show similar immunophenotypes. The Breast. 16(4). 352–358. 15 indexed citations
16.
Lemarié, Claude, Benjamin Esterni, Boris Calmels, et al.. (2007). CD34+ progenitors are reproducibly recovered in thawed umbilical grafts, and positively influence haematopoietic reconstitution after transplantation. Bone Marrow Transplantation. 39(8). 453–460. 16 indexed citations
17.
Ginestier, Christophe, Nathalie Cervera, Pascal Finetti, et al.. (2006). Prognosis and Gene Expression Profiling of 20q13-Amplified Breast Cancers. Clinical Cancer Research. 12(15). 4533–4544. 107 indexed citations
18.
Vv, Ivanov, Catherine Faucher, Mohamad Mohty, et al.. (2005). Early administration of recombinant erythropoietin improves hemoglobin recovery after reduced intensity conditioned allogeneic stem cell transplantation. Bone Marrow Transplantation. 36(10). 901–906. 11 indexed citations
19.
Jourdan, Éric, Jean‐Michel Boiron, Nicole Dastugue, et al.. (2005). Early Allogeneic Stem-Cell Transplantation for Young Adults With Acute Myeloblastic Leukemia in First Complete Remission: An Intent-to-Treat Long-Term Analysis of the BGMT Experience. Journal of Clinical Oncology. 23(30). 7676–7684. 39 indexed citations
20.
Brenot-Rossi, I., Stéphane Garcia, Stéphane Dumas, et al.. (2005). Limited pelvic lymphadenectomy using the sentinel lymph node procedure in patients with localised prostate carcinoma: a pilot study. European Journal of Nuclear Medicine and Molecular Imaging. 32(6). 635–640. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nashat Gabrail Breakdown of academic impact, for papers by Marco Danova Breakdown of academic impact, for papers by Lia Gore Breakdown of academic impact, for papers by Giannoula Klement Breakdown of academic impact, for papers by Mohamed Hebbar Breakdown of academic impact, for papers by David Boulware Breakdown of academic impact, for papers by Peter Langmuir Breakdown of academic impact, for papers by J Garcı́a-Conde Breakdown of academic impact, for papers by Margaret Dugan Breakdown of academic impact, for papers by Barbara Schmalfeldt
Rankless by CCL
2026